Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Nasal Spray Formulations : SOP for Stability Studies of Nasal Formulations

Posted on By




SOP for Stability Studies of Nasal Formulations



Standard Operating Procedure for Stability Studies of Nasal Formulations

1) Purpose

This SOP outlines the procedures required for conducting stability studies of nasal formulations, which evaluate the physical, chemical, and microbiological stability of the product over time under various storage conditions.

2) Scope

This SOP applies to personnel involved in conducting stability studies on nasal formulations, including sprays, powders, and gels, to ensure that the products meet shelf-life and regulatory requirements.



SOP for Hot Melt Extrusion Process for Nasal Powders



Standard Operating Procedure for Hot Melt Extrusion Process for Nasal Powders

1) Purpose

The purpose of this SOP is to outline the procedures for using the

hot melt extrusion (HME) process to manufacture nasal powders. This process allows the formation of stable, solid dispersions of active pharmaceutical ingredients (APIs) with polymers, enhancing the drug’s bioavailability and stability.

2) Scope

This SOP applies to all personnel involved in the preparation, testing, and quality control of nasal powder formulations made using the hot melt extrusion process at [Company Name].

3) Responsibilities

  • Operators: Responsible for setting up, operating, and monitoring the hot melt extrusion process and ensuring the correct parameters are followed.
  • Quality Assurance (QA): Ensures that the extrusion process meets the required specifications for temperature, pressure, and homogeneity.
  • Maintenance Team: Responsible for cleaning and calibrating the extrusion equipment.
See also  SOP for Operation of Nasal Spray Filling Machines

4) Procedure

4.1 Preparation of Materials

4.1.1 Selection of API and Polymers

  • Select the active pharmaceutical ingredients (APIs) and polymers based on their suitability for the hot melt extrusion process. The API must be thermally stable, and the polymer must be capable of forming a solid dispersion.
  • Commonly used polymers for hot melt extrusion include ethylcellulose, Eudragit, and hydroxypropyl cellulose. Record the selection of API and polymer in the batch manufacturing record (BMR).

4.1.2 Weighing of Ingredients

  • Weigh the required amount of API and polymer using a calibrated balance. Document the weights in the BMR, ensuring that all components are within ±2% of the target weight.

4.2 Hot Melt Extrusion Process

4.2.1 Equipment Setup

  • Set up the hot melt extrusion equipment according to the manufacturer’s instructions. Ensure the extruder barrel, screw, and die are clean and ready for use. Perform a pre-operation check to verify the equipment’s functionality.
  • Calibrate the temperature controls and extrusion pressure settings to ensure they are within the specified range for the formulation. Document the calibration results in the equipment calibration log.

4.2.2 Loading and Extrusion

  • Load the weighed API and polymer into the extruder’s feed hopper. Set the extruder’s barrel temperature, screw speed, and pressure according to the BMR.
  • As the materials pass through the heated barrel, monitor the temperature and pressure at different zones to ensure they remain within the target range. Adjust the settings as necessary to maintain consistent output.
See also  SOP for Preparation of Nasal Sprays for Targeted Brain Delivery

4.2.3 Collection and Cooling

  • Once the material exits the die, collect the extrudate and transfer it to a cooling tray or conveyor. Ensure that the material cools rapidly to prevent degradation or sticking.
  • Record the extrusion parameters, including barrel temperature, screw speed, and pressure, in the BMR.

4.3 Milling and Sieving

4.3.1 Milling Process

  • After cooling, transfer the extrudate to a milling machine to reduce the particle size of the nasal powder. Set the milling speed and time according to the BMR.
  • Test the particle size distribution using a particle size analyzer and ensure it falls within the target range (typically 1-10 microns for nasal powders).

4.3.2 Sieving

  • Pass the milled powder through a fine mesh sieve to ensure uniformity in particle size. Collect the sieved powder in a clean, dry container and record the yield in the BMR.

4.4 Quality Control Testing

4.4.1 Particle Size Distribution

  • Test the particle size distribution of the nasal powder using a laser diffraction particle size analyzer. Ensure the particle size falls within the target range.
  • Record the results in the particle size testing log.

4.4.2 Stability Testing

  • Conduct stability testing of the nasal powder by storing samples at controlled environmental conditions (e.g., 25°C, 60% RH) and testing them at regular intervals (e.g., 1 month, 3 months, 6 months).
  • Document all stability test results in the stability testing log.

4.5 Documentation

  • Document all steps of the hot melt extrusion process, including material loading, temperature, pressure settings, and milling/sieving procedures, in the BMR.
  • Ensure QA personnel review and sign off on the documentation before releasing the product.
See also  SOP for Preventing Cross-Contamination in Production

4.6 Equipment Cleaning and Calibration

  • After completing the batch, clean and sterilize the hot melt extrusion equipment and milling machines following the cleaning validation protocol.
  • Calibrate the equipment as per the calibration schedule and document the results in the calibration log.

5) Abbreviations, if any

  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • Particle Size Testing Log
  • Stability Testing Log
  • Cleaning Log
  • Calibration Log

7) References, if any

  • ICH Q1A – Stability Testing Guidelines
  • FDA Guidance for Nasal Drug Products

8) SOP Version

Version 1.0

Annexure

1. Particle Size Testing Log Template

Date Formulation Particle Size (µm) Test Method Operator Initials QA Approval
DD/MM/YYYY Formulation Name Size Method Operator Name QA Name
           

2. Stability Testing Log Template

Date Formulation Storage Conditions Time Interval Stability Results Operator Initials QA Approval
DD/MM/YYYY Formulation Name Temperature and Humidity 1 month, 3 months, etc. Pass/Fail Operator Name QA Name
           

3. Cleaning Log Template

Date Equipment ID Cleaning Procedure Operator Initials QA Approval
DD/MM/YYYY Equipment Name/ID Cleaning Method Operator Name QA Name
           

4. Calibration Log Template

Date Equipment ID Calibration Procedure Calibration Results Operator Initials QA Approval
DD/MM/YYYY Equipment Name/ID Procedure Pass/Fail Operator Name QA Name
           


Nasal Spray Formulations Tags:Cleaning SOP for nasal spray equipment, Environmental control in nasal spray production, Equipment maintenance for nasal sprays, Formulating isotonic nasal sprays, Microbial stability in nasal formulations, Mixing SOP for nasal formulations, Nasal spray API formulation, Nasal spray batch manufacturing SOP, Nasal spray filling machine operation, Nasal spray formulation process, Nasal spray GMP guidelines, Nasal spray homogenization techniques, Nasal spray manufacturing process, Nasal spray packaging SOP, Nasal spray preservative-free formulation, Nasal spray production SOP, Nasal spray stability studies, Nasal spray sterilization process, Nasal spray viscosity monitoring, Particle size control in nasal sprays, pH adjustment in nasal formulations, Quality control in nasal spray production, Solvent selection for nasal sprays, SOP for nasal spray manufacturing, SOP for nasal spray testing

Post navigation

Previous Post: SOP for Use of Excipients in Lyophilized Formulations
Next Post: SOP for Preparation of Monoclonal Antibody Lyophilized Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version